Sven Kili, Partner, Saisei Ventures | Onyx Live | Cell & Gene Meeting on the Med 2026
Great science isn't enough to get funded, says investor Sven Kili – only great medicines are. Inside the CGT funding squeeze, and what specialist VCs actually screen for.